All Type of News
Safety profile of phenylpropanolamine-containing cold remedies needs to be reviewed, symposium says
The Korea Doctors Association held a symposium titled "Are phenylpropanolamine (PPA)-containing cold remedies dangerous to the people?" on October 15 at Dong-A hall.
Citing the results of a hemorrhagic cerebral apo...
Wholesalers disappointed in OTC drug business slow
The OTC oriented drug wholesalers who had expected an OTC drug business rise in the cold season have disappointed in depressed markets. The similar response was also found in most of domestic drug manufacturers who us...
Ethical drug advertising through internet to be controlled.
The KFDA announced that the advertising of ethical drugs through any pharmaceutical professional website media would be curbed in view of preventing drug abuse and misuse.
The medical and pharmaceutical website co...
Tasks required to nurture domestic pharmaceutical firms' competitiveness
In light of the increasingly competitive pharmaceutical environment in the global market, domestic drug makers should retain better profitability in a bide to ensure substantial R&D spending, strengthened export drive...
Extension of temporary measures concerning designation of psychotropic drugs eyed
The Korea Food and Drug Administration announced it would extend its 60-day temporary measures concerning the recent designation of psychotropic drugs (dextromethorphan, and carisoprodol and its salt) based on the pre...
Janssen Korea to file application for new anticancer in early next yearJanssen Korea said it would file a new application for Velcade, proteasome inhibitor in early next year in line with its launching program.
The U.S. FDA announced on May 13 t...
|
Quality of Kyeongbo's Bacampicillin bulk approved in Europe.Kyeongbo Pharmaceutical company (President: Kim Young-eun) announced that the bulk of Bacampicillin Hcl, a semi-synthetic penicillin, had obtained its Certificate of Suitability...
|
Test on Rispedal to prove promising treatment of maniac patients.A new drug called Rispedal (risperidone) originally developed by Janssen was found very effective for mania in the treatment of manic-depressive patient when combining with an a...
|
Pfizer Korea's Plunazol-related claim for damage is unlikely to affect Daewoong Pharm
Hanyang Securities Co. said that Pfizer Korea submitted to Seoul District Court its claim for damage against patent infringement of Daewoong Pharm over Plunazol, which annualized domestic sales of 23.8 billion won las...
Novartis Korea to launch IBS medication in domestic marketNovartis Korea, a Korean unit of Switzerland-based multinational pharmaceutical firm, said it would soon roll out Zelmac (tegasorod) into domestic pharmaceutical market.
Te...
|
